InvestorsHub Logo
Followers 276
Posts 54374
Boards Moderated 3
Alias Born 08/16/2008

Re: None

Thursday, 07/18/2024 9:57:45 AM

Thursday, July 18, 2024 9:57:45 AM

Post# of 13
BRIEF-Phathom Pharmaceuticals Announces FDA Approval Of Voquezna® (Vonoprazan) Tablets For The Relief Of Heartburn Associated With Non-Erosive Gerd In Adults
REUTERS

Jul-18-2024 8:41 a.m. ET

July 18 (Reuters) - Phathom Pharmaceuticals Inc (PHAT) :

* PHATHOM PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF VOQUEZNA® (VONOPRAZAN) TABLETS FOR THE RELIEF OF HEARTBURN ASSOCIATED WITH NON-EROSIVE GERD IN ADULTS

* PHATHOM PHARMACEUTICALS INC (PHAT): VOQUEZNA MET ITS PRIMARY ENDPOINT IN ITS PHASE 3 PIVOTAL TRIAL Source text for Eikon: Further company coverage:
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHAT News